P/E ratio for Viveve Medical (VIVE)
P/E ratio as of April 2024 (TTM): -0.0001
According to Viveve Medical 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -7.54717E-5. At the end of 2021 the company had a P/E ratio of -0.4254.
P/E ratio history for Viveve Medical from 2010 to 2022
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2021 | -0.4254 | 66.62% |
| 2020 | -0.2553 | 1079.58% |
| 2019 | -0.0216 | -96.64% |
| 2018 | -0.6439 | -72.27% |
| 2017 | -2.32 | 0.11% |
| 2016 | -2.32 | -2.88% |
| 2015 | -2.39 | 348.58% |
| 2014 | -0.5325 | -107.64% |
| 2013 | 6.97 | -1590.9% |
| 2012 | -0.4674 | -13.41% |
| 2011 | -0.5398 | -86.02% |
| 2010 | -3.86 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 PAVmed
PAVM | -2.07 | 2,736,660.93% | 🇺🇸 USA |
 Philips PHG | -29.6 | 39,166,104.02% | 🇳🇱 Netherlands |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.